269 related articles for article (PubMed ID: 11262183)
1. A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons.
Alvarez A; Muñoz JP; Maccioni RB
Exp Cell Res; 2001 Apr; 264(2):266-74. PubMed ID: 11262183
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death.
Alvarez A; Toro R; Cáceres A; Maccioni RB
FEBS Lett; 1999 Oct; 459(3):421-6. PubMed ID: 10526177
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases beta-amyloid toxicity in cortical neurons.
Li G; Faibushevich A; Turunen BJ; Yoon SO; Georg G; Michaelis ML; Dobrowsky RT
J Neurochem; 2003 Jan; 84(2):347-62. PubMed ID: 12558997
[TBL] [Abstract][Full Text] [Related]
4. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
[TBL] [Abstract][Full Text] [Related]
5. A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons.
Zheng YL; Kesavapany S; Gravell M; Hamilton RS; Schubert M; Amin N; Albers W; Grant P; Pant HC
EMBO J; 2005 Jan; 24(1):209-20. PubMed ID: 15592431
[TBL] [Abstract][Full Text] [Related]
6. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology.
Maccioni RB; Otth C; Concha II; Muñoz JP
Eur J Biochem; 2001 Mar; 268(6):1518-27. PubMed ID: 11248668
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of TNFalpha against the beta-amyloid neurotoxicity mediated by CDK5 kinase.
Orellana DI; Quintanilla RA; Maccioni RB
Biochim Biophys Acta; 2007 Feb; 1773(2):254-63. PubMed ID: 17150266
[TBL] [Abstract][Full Text] [Related]
8. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.
Seyb KI; Ansar S; Li G; Bean J; Michaelis ML; Dobrowsky RT
J Mol Neurosci; 2007; 31(1):23-35. PubMed ID: 17416967
[TBL] [Abstract][Full Text] [Related]
9. Cyclin-dependent kinase 5 activator p35 over-expression and amyloid beta synergism increase apoptosis in cultured neuronal cells.
Utreras E; Maccioni R; González-Billault C
Neuroscience; 2009 Jul; 161(4):978-87. PubMed ID: 19362124
[TBL] [Abstract][Full Text] [Related]
10. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
Hisanaga S; Saito T
Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
[TBL] [Abstract][Full Text] [Related]
11. [Ginsenoside Rb1 attenuates beta-amyloid peptide(25-35) -induced hyperphosphorylation of tau protein through CDK5 signal pathway].
Xie YH; Chen XC; Zhang J; Huang TW; Song JQ; Fang YX; Pan XD; Lin ZY
Yao Xue Xue Bao; 2007 Aug; 42(8):828-32. PubMed ID: 17944229
[TBL] [Abstract][Full Text] [Related]
12. The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2001 Feb; 280(4):998-1002. PubMed ID: 11162625
[TBL] [Abstract][Full Text] [Related]
13. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264
[TBL] [Abstract][Full Text] [Related]
14. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
Patrick GN; Zukerberg L; Nikolic M; de la Monte S; Dikkes P; Tsai LH
Nature; 1999 Dec; 402(6762):615-22. PubMed ID: 10604467
[TBL] [Abstract][Full Text] [Related]
15. p35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent Extracellular Signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neurons.
Kesavapany S; Amin N; Zheng YL; Nijhara R; Jaffe H; Sihag R; Gutkind JS; Takahashi S; Kulkarni A; Grant P; Pant HC
J Neurosci; 2004 May; 24(18):4421-31. PubMed ID: 15128856
[TBL] [Abstract][Full Text] [Related]
16. CDK5 Participates in Amyloid-β Production by Regulating PPARγ Phosphorylation in Primary Rat Hippocampal Neurons.
Quan Q; Qian Y; Li X; Li M
J Alzheimers Dis; 2019; 71(2):443-460. PubMed ID: 31403945
[TBL] [Abstract][Full Text] [Related]
17. Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies.
Lopes JP; Oliveira CR; Agostinho P
Cell Mol Neurobiol; 2007 Nov; 27(7):943-57. PubMed ID: 17965932
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2002 Nov; 298(5):693-8. PubMed ID: 12419309
[TBL] [Abstract][Full Text] [Related]
19. Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Abeta (25-35): involvement of lipid rafts.
Hernandez P; Lee G; Sjoberg M; Maccioni RB
J Alzheimers Dis; 2009; 16(1):149-56. PubMed ID: 19158430
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine prevents beta-amyloid toxicity by a stimulatory effect on p35/cyclin-dependent kinase 5 activity in cultured cortical neurons.
Hsiao YH; Chen PS; Yeh SH; Lin CH; Gean PW
J Neurosci Res; 2008 Sep; 86(12):2685-95. PubMed ID: 18512759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
